control group:conventional treatment+ placebo

2 trials

Sponsors

Longhua Hospital Affiliated Shanghai University of TCM, The Third Affiliated Hospital of Zhejiang Chinese Medical University

Conditions

IgA nephropathyMulti-drug resistant pulmonary tuberculosis (MDR-PTB)

Unknown Phase

Multicenter, Randomized and Double-blind Controlled Clinical Trial of Integrative Medicine Therapy for Treatment of multi-drug-resistant pulmonary tuberculosis

RecruitingChiCTR-TRC-12002850

Longhua Hospital Affiliated Shanghai University of TCMMulti-drug resistant pulmonary tuberculosis (MDR-PTB)

Start: 2012-12-05Updated: 2017-04-18

A randomized controlled study of Yiqi Yangyin Qufeng Formula in the treatment of early stage IgA nephropathy

Active, not recruitingITMCTR2025000277

The Third Affiliated Hospital of Zhejiang Chinese Medical UniversityIgA nephropathy

Start: 2025-06-01Updated: 2025-03-03

Related Papers

Efficacy and Safety of Bufei Jiedu Granules in Treating Multidrug-Resistant Pulmonary Tuberculosis: A Multi-center, Double-Blinded and Randomized Controlled Trial.

2024-05-111 citations